CoChat

Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures

Open access
Galson, Jacob D., Schaetzle, Sebastian, Bashford-Rogers, Rachael J. M., Raybould, Matthew I. J., Kovaltsuk, Aleksandr, Kilpatrick, Gavin J., Minter, Ralph, Finch, Donna K., Dias, Jorge, James, Louisa K., Thomas, Gavin, Lee, Wing-Yiu Jason, Betley, Jason, Cavlan, Olivia, Leech, Alex, Deane, Charlotte M., Seoane, Joan, Caldas, Carlos, Pennington, Daniel J., Pfeffer, Paul, Osbourn, Jane · 2020 · Frontiers in Immunology

Published version of a preprint

Cited by 139

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Deep sequencing of B cell receptor (BCR) heavy chains from a cohort of 31 COVID-19 patients from the UK reveals a stereotypical naive immune response to SARS-CoV-2 which is consistent across patients. Clonal expansion of the B cell population is also observed and may be the result of memory bystander effects. There was a strong convergent sequence signature across patients, and we identified 1,254 clonotypes convergent between at least four of the COVID-19 patients, but not present in healthy controls or individuals following seasonal influenza vaccination. A subset of the convergent clonotypes were homologous to known SARS and SARS-CoV-2 spike protein neutralizing antibodies. Convergence was also demonstrated across wide geographies by comparison of data sets between patients from UK, USA, and China, further validating the disease association and consistency of the stereotypical immune response even at the sequence level. These convergent clonotypes provide a resource to identify potential therapeutic and prophylactic antibodies and demonstrate the potential of BCR profiling as a tool to help understand patient responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.605170

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 42

  1. Lu, 2020, Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle, J Med Virol, 92, 10.1002/jmv.25678 · DOI · Paper page
  2. Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  3. Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
  4. Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 10.1056/NEJMoa1910993 · DOI · Paper page
  5. Gogtay, 2018, Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study, Clin Infect Dis, 66, 10.1093/cid/cix791 · DOI
  6. Johnson, 1997, Development of a Humanized Monoclonal Antibody (MEDI-493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus, J Infect Dis, 176, 10.1086/514115 · DOI · Paper page
  7. Wang, 2014, Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins, Biochem Biophys Res Commun, 451, 10.1016/j.bbrc.2014.07.090 · DOI · Paper page
  8. Tetro, 2020, Is COVID-19 receiving ADE from other coronaviruses, Microbes Infect, 22, 10.1016/j.micinf.2020.02.006 · DOI · Paper page
  9. Sharma, 2020, It is too soon to attribute ADE to COVID-19, Microbes Infect, 22, 158, 10.1016/j.micinf.2020.03.005 · doi:10.1016/j.micinf.2020.03.005
  10. Wang, 2016, Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates, ACS Infect Dis, 2, 10.1021/acsinfecdis.6b00006 · DOI · Paper page
  11. Andreano, 2020, Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients, bioRxiv, 10.1101/2020.05.05.078154 · DOI
  12. Nielsen, 2020, Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2, Cell Host Microbe, 28, 516, 10.1016/j.chom.2020.09.002 · DOI · Paper page
  13. De Mattos-Arruda, 2019, The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer, Cell Rep, 27, 2690, 10.1016/j.celrep.2019.04.098 · DOI
  14. van Dongen, 2003, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia, 17, 10.1038/sj.leu.2403202 · DOI · Paper page
  15. Vander Heiden, 2014, pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires, Bioinformatics, 30, 10.1093/bioinformatics/btu138 · DOI · Paper page
  16. Gupta, 2015, Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data, Bioinformatics, 31, 10.1093/bioinformatics/btv359 · DOI · Paper page
  17. Edgar, 2010, Search and clustering orders of magnitude faster than BLAST, Bioinformatics, 26, 10.1093/bioinformatics/btq461 · DOI · Paper page
  18. Ye, 2013, IgBLAST: an immunoglobulin variable domain sequence analysis tool, Nucleic Acids Res, 41, 10.1093/nar/gkt382 · DOI · Paper page
  19. Ghraichy, 2020, Maturation of the Human B-Cell Receptor Repertoire with Age, Front Immunol, 11, 1734, 10.2139/ssrn.3518535 · doi:10.2139/ssrn.3518535
  20. Tipton, 2015, Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus, Nat Immunol, 16, 10.1038/ni.3175 · DOI · Paper page
  21. Gupta, 2017, Hierarchical Clustering Can Identify B Cell Clones with High Confidence in Ig Repertoire Sequencing Data, J Immunol, 198, 10.4049/jimmunol.1601850 · DOI · Paper page
  22. Galson, 2015, BCR repertoire sequencing: different patterns of B cell activation after two Meningococcal vaccines, Immunol Cell Biol, 93, 10.1038/icb.2015.57 · DOI · Paper page
  23. Gupta, 2015, Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data, Bioinformatics, 1, 10.1093/bioinformatics/btv359 · DOI · Paper page
  24. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 10.1038/s41586-020-2012-7 · DOI · Paper page
  25. Bolotin, 2015, MiXCR: software for comprehensive adaptive immunity profiling, Nat Methods, 12, 10.1038/nmeth.3364 · DOI · Paper page
  26. Wickham, 2009, ggplot2: Elegant Graphics for Data Analysis, 10.1007/978-0-387-98141-3 · DOI · Paper page
  27. Tavakolpour, 2020, Lymphopenia during the COVID-19 infection: What it shows and what can be learned, Immunol Lett, 225, 10.1016/j.imlet.2020.06.013 · DOI · Paper page
  28. Pascual, 1991, Nucleotide sequence analysis of the V regions of two IgM cold agglutinins: Evidence that the V(H)4-21 gene segment is responsible for the major cross-reactive idiotype, J Immunol, 146, 10.4049/jimmunol.146.12.4385 · DOI · Paper page
  29. Horns, 2016, Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching, Elife, 5, 1, 10.7554/eLife.16578 · DOI
  30. Parameswaran, 2013, Convergent Antibody Signatures in Human Dengue, Cell Host Microbe, 13, 691, 10.1016/j.chom.2013.05.008 · DOI · Paper page
  31. Zost, 2020, Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein, Nat Med, 26, 10.1038/s41591-020-0998-x · DOI · Paper page
  32. Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Sci (80- ), 369, 10.1126/science.abc7520 · DOI · Paper page
  33. Seydoux, 2020, Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual, bioRxiv, 10.1101/2020.05.12.091298 · DOI · Paper page
  34. Li, 2020, IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity, bioRxiv, 10.1101/2020.05.15.096719 · DOI
  35. Wec, 2020, Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine, Proc Natl Acad Sci USA, 117, 10.1073/pnas.1921388117 · DOI · Paper page
  36. Tian, 2008, Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones, J Immunol, 180, 10.4049/jimmunol.180.5.3279 · DOI
  37. Godoy-Lozano, 2016, Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response, Genome Med, 8, 23, 10.1186/s13073-016-0276-1 · DOI
  38. Kalinke, 2000, Virus neutralization by germ-line vs. hypermutated antibodies, Proc Natl Acad Sci USA, 97, 10.1073/pnas.97.18.10126 · doi:10.1073/pnas.97.18.10126
  39. Wec, 2020, Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein, bioRxiv, 10.1101/2020.05.15.096511 · DOI
  40. Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci, 117, 202004168, 10.1073/pnas.2004168117 · DOI · Paper page
  41. Galson, 2020, Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures, bioRxiv, 10.1101/2020.05.20.106294 · DOI
  42. Corrie, 2018, iReceptor: A platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories, Immunol Rev, 284, 24, 10.1111/imr.12666 · DOI · Paper page

Cited by

See all 139

Metadata

Authors
Galson, J. D., Schaetzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J., James, L. K., Thomas, G., Lee, W.-Y. J., Betley, J., Cavlan, O., Leech, A., Deane, C. M., Seoane, J., Caldas, C., Pennington, D. J., Pfeffer, P., & Osbourn, J.
Venue
Frontiers in Immunology
Published
2020-12-15
Volume
11
Pages
605170-605170
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3111287171
Cited by
139
References
12
FWCI
2.78
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures. https://app.cochat.ai/papers/10.3389/fimmu.2020.605170
The paper
Galson, J. D., Schaetzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J., James, L. K., Thomas, G., Lee, W.-Y. J., Betley, J., Cavlan, O., Leech, A., Deane, C. M., Seoane, J., Caldas, C., Pennington, D. J., . . . Osbourn, J. (2020). Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.605170

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.